FDA Approves Third Tocilizumab Biosimilar
The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as the originator tocilizumab, Actemra.
👉 Full Story
Statins only add 3 DAYS to your life?!?
- Watch the Kulhad Pizza Couple New Viral Video - Aaradhana Chaurasia
- ECU Health’s Dr. Jonathan Hamilton honored with Patriot Award - Jerry.Grimes@ecuhealth.org
- Balancing AI Hype And Practical Innovation - Deborah Ritchie
- Exploring SVG Format: A Superior Choice for Modern Web Design - Michael A. Medeiros
- TikTok Unveils New 'Add to Music App' Feature in Partnership with Major Music Streaming Services - Bertha Stephens
- Larger Medical Bankruptcies Less Frequent in 2024: Report
New York City TEENS Steal Train
- Magazine Dreams | Official Trailer – In Theaters March 21st - Staff
- Infamous R-Rated Mystery Thriller On Max Is Must-See From Master Filmmaker - Jonathan Klotz
- Philippines to Remove US Missile System If China Ends ‘Coercive Behavior’ - MeighTimbol
- The Implications of ChatGPT's Upcoming Video-Creation Capabilities - Michael Terry
- OpenAI's $51 Million Investment in Neuromorphic Chips: A Step Towards Brain-like AI - Michael Terry
- On The Hidden Money Trail: S-RM Sam Taylor Q&A - Andrew Singer